Revenue segments as reported by the company.

Premiums earned, net

Other income

Investment income, net

Direct Contracting revenue

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Net medical claims incurred

Salaries and benefits

General and administrative expenses

Premium deficiency reserve (benefit) expense

Depreciation and amortization

Other expense

Restructuring costs

Impairment of goodwill and other intangible assets

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Clover Health Investments

Clover Health Investments Corp. provides healthcare insurance services. It uses its proprietary technology platform to collect, structure, and analyze health and behavioral data to improve medical outcomes and lower costs for patients. The company was founded on July 17, 2014 and is headquartered in Franklin, TN.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Clover Health reports profitable Q1, poised for sustained growth

Clover Health Investments had a strong Q1 performance, expecting full-year profitability and revenue growth. With a focus on operational enhancements, revenue growth, and cost reductions, the company aims to maintain momentum in 2024 amidst industry challenges. Clover's strategic initiatives like share repurchase program and product enhancements position it well for sustained growth and care management excellence.

Clover Health achieves profitability milestone and eyes market expansion

Clover Health's Q2 2024 earnings call reflects a positive trajectory with increased profitability, strong revenue growth, and improved guidance for the full year.
The company's strategic focus on operational efficiency, technology innovation, and market validation positions it well for sustainable growth and market expansion.
While facing challenges in maintaining profitability and implementing technology enhancements, Clover Health has opportunities to capitalize on market interest and drive further growth in the Medicare Advantage sector.

Clover Health reports strong Q3 performance and eyes growth opportunities

Clover Health Investments (CLOV) showcased strong financial performance and strategic investments in growth areas during the Q3 2024 earnings call. The company's focus on membership growth, quality initiatives, and technology enhancements, along with exploring health partnerships, highlights a promising outlook for future success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Clover Health Investments Corp. is a physician enablement technology company that provides Medicare Advantage plans in the United States. Its strategy is powered by its proprietary software platform, Clover Assistant, which aggregates patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic diseases. The company offers PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on its flagship wide-network, high-choice PPO plans. Clover Health Investments was founded by Vivek Garipalli and Andrew Toy on July 17, 2014 and is headquartered in Franklin, TN.

Clover Health and CLOV stock rest in the hands of its direct contracting (DC) business. A new model could hinder or help its business.

Here's the One Thing That Could Make or Break Clover Health Stock

As the situation for Clover Health may not be as bad as once feared, now may be the time to buy hard-hit former meme favorite CLOV stock. The post Recent Results Signal Clover Stock Is a Worthy High-Risk Wager appeared first on InvestorPlace.

Recent Results Signal Clover Stock Is a Worthy High-Risk Wager

A U.S. judge has ruled that venture investor Chamath Palihapitiya, Clover Health Investments Corp and its executives must face a lawsuit that claims they misled investors about the health insurance company when it went public via one of Palihapitiya's many special purpose acquisition companies.

U.S. judge says Palihapitiya must face Clover shareholders' lawsuit

Due to the worrying geopolitical flashpoint, CLOV stock seemed far too risky. But an unexpected hero may change everything.

Surprising Global Optimism Could Help Clover Health Stock Recover

CLOV earnings show improving profitability and promising 2022 guidance.

Good News From Clover Health

FuelCell Energy

Gran Tierra Energy

Check these penny stocks out as Russia invades Ukraine The post Penny Stocks to Watch During High Market Volatility  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Penny Stocks to Watch During High Market Volatility

An earnings beat and an improved outlook make this digital healthcare stock hard to ignore.

Clover Health Blows Past Expectations. Time to Buy?

Clover Health Investments, Corp. (CLOV) CEO Vivek Garipalli on Q4 2021 Results - Earnings Call Transcript

Fourth quarter total revenue was $432.0 million, up 160% year-over-year, enabled by a wide, open network designed to serve all Medicare lives

Clover Health Reports Fourth Quarter 2021 Financial Results

Here's what some expert analysts think about Clover Health and CLOV stock amid the stock's impressive decline to new 52-week lows. The post Is CLOV Stock a Buy at 52-Week Lows?

Is CLOV Stock a Buy at 52-Week Lows? 3 Analysts Weigh In on Clover Health.

AMC Entertainment

Ocugen, Inc.

Peloton

QuantumScape

SoFi Technologies

Zillow

These stocks to sell run the gamut in terms of industry, but they all have one thing in common: the pros think they ought to be sold. The post 7 Popular Stocks That Pros Agree You Should Punt From Your Portfolio appeared first on InvestorPlace.

7 Popular Stocks That Pros Agree You Should Punt From Your Portfolio

Clover Health Investments Corp (NASDAQ: CLOV) is ripping higher in Wednesday's after-hours session after the company released its fourth-quarter financial results.  Clover Health said fourth-quarter revenue increased 160% year-over-year to $432 million.

Why Clover Health Shares Are Surging After Hours

eBay

Skillz

Markets were closed Monday in observance of Presidents Day. Even so, a couple of intrepid energy companies chose to report results when no one was around to hear them.

Earnings Previews: Clover Health, eBay, Skillz, TJX

The Clover Health Investments Corporation (NASDAQ: CLOV) stock is trending today. This is why.

Clover Health (CLOV) Stock: Why Its Trending Today

FRANKLIN, Tenn., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Clover Health (Nasdaq: CLOV), a technology company committed to improving health equity for seniors, today announced that its CEO, Vivek Garipalli, and President, Andrew Toy, will present at Citi's 2022 Virtual Healthcare Conference on Thursday, February 24, 2022, at 2:45 p.m. Eastern Time.

Clover Health to Present at Citi's 2022 Virtual Healthcare Conference on February 24, 2022

Joby Aviation

Are these penny stocks on your watchlist right now? The post Check These 3 Penny Stocks Out For Your February Watchlist  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Check These 3 Penny Stocks Out For Your February Watchlist

The situation behind CLOV stock is spiraling from bad to worse. A sale of the company may be the only option to keep Clover Health running.

A Buyout May Be the Best Hope for Clover Health Now

Clover Health Investments (CLOV) stock is on the move Wednesday following a new price prediction from Cowen analyst Gary Taylor. The post CLOV Stock Price Predictions: Why One Analyst See Clover Health Shares Hitting $7 appeared first on InvestorPlace.

CLOV Stock Price Predictions: Why One Analyst See Clover Health Shares Hitting $7

NASHVILLE, Tenn., Jan. 25, 2022 (GLOBE NEWSWIRE) -- Clover Health (Nasdaq: CLOV), a technology company committed to improving health equity for America's underserved seniors, today announced that it will report fourth quarter and full year 2021 financial results after market close on Wednesday, February 23, 2022. On that day management will host a conference call and webcast at 5:00 p.m. Eastern Time to discuss the company's business and financial results.

Clover Health to Report Fourth Quarter and Full Year 2021 Financial Results on February 23, 2022

With CLOV stock, it may be worth rolling the dice at today's prices.  The post At Below $3 Clover Health Stock May Be Worth It as a Moonshot appeared first on InvestorPlace.

At Below $3 Clover Health Stock May Be Worth It as a Moonshot

Both Clover Health's bear and bull cases are equally compelling, which makes CLOV stock a highly risky bet right now. The post Clover Health Stock Remains a High-Risk High-Reward Play appeared first on InvestorPlace.

Clover Health Stock Remains a High-Risk High-Reward Play

CLOV lost its growth premium in the recent market selloff, and the company now trades at a discount to peers' price multiples. Our buy rating rests on the management's ability to tweak and hone its operations to reach profitability.

Clover Health Is Now Undervalued, But Gains Not Guaranteed

You can hold CLOV stock in hopes of another Reddit run-up, but there are also positive data points to support a long-term investment. The post Membership Growth Is Making Clover Health a More Convincing Investment appeared first on InvestorPlace.

Membership Growth Is Making Clover Health a More Convincing Investment

Social Capital Hedosophia Holdings Corp. III

NEW YORK, Jan. 18, 2022 /PRNewswire/ -- Moore Kuehn, PLLC, a securities and shareholder law firm located on Wall Street, is investigating potential claims against: Clover Health Investments Corp. (NASDAQ: CLOV) formerly known as Social Capital Hedosophia Holdings Corp. III (NYSE: IPOC) Please contact only if you acquired shares before November 17, 2020 . The Clover Health Investments Corp. / Social Capital Hedosophia Holdings Corp. investigation is based on allegations that the company or its officers and directors misrepresented and failed to disclose adverse facts about its business, operations, and prospects and due diligence activities in connection with the merger, which were known or recklessly disregarded.

Moore Kuehn, PLLC Encourages Investors of Clover Health Investments Corp. formerly known as Social Capital Hedosophia Holdings Corp. III to Contact Law Firm if Purchased Before November 17, 2020

CTO Andrew Toy's innovations like Clover Assistant, seen by some as savior of CLOV stock, are already being adopted by larger Medicare Advantage players. The post Clover Health Stock Investors Will Need to Buy Into Tech Chief's Vision appeared first on InvestorPlace.

News for Clover Health Investments Stock (CLOV)